Frédéric Forget
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Hematology top 10%
- Hepatology top 10%
- Co-authors
- Gaston DemontyFernando RiveraMeinolf KarthausXuesong GuanIsabel SevillaGianpiero FasolaHoward SafranLee S. Schwartzberg
- Topics
- Advanced Breast Cancer Therapies (7 papers)Cancer Immunotherapy and Biomarkers (7 papers)Cancer Treatment and Pharmacology (7 papers)
- Cited by
- OncologyHepatologyHematology
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Frédéric Forget
34 papers receiving 501 citations
Peers
Comparison fields: 5 of 62
- Oncology 251
- Pulmonary and Respiratory Medicine 166
- Molecular Biology 104
- Hematology 86
- Hepatology 67
Countries citing papers authored by Frédéric Forget
This map shows the geographic impact of Frédéric Forget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Forget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Forget more than expected).
Fields of papers citing papers by Frédéric Forget
This network shows the impact of papers produced by Frédéric Forget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Forget. The network helps show where Frédéric Forget may publish in the future.
Co-authorship network of co-authors of Frédéric Forget
This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Forget. A scholar is included among the top collaborators of Frédéric Forget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Forget. Frédéric Forget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 12 | |
| 6 | 12 | |
| 7 | 24 | |
| 8 | 17 | |
| 9 | 14 | |
| 10 | 36 | |
| 11 | 79 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 18 | |
| 15 | 2 | |
| 16 | 8 | |
| 17 | 37 | |
| 18 | 64 | |
| 19 | 5 | |
| 20 | A phase I, clinical and pharmacokinetic (PK) trial of the farnesyl transferase inhibitor (FTI) R115777 + docetaxel : a promising combination in patients (pts) with solid tumors | 36 |
About Frédéric Forget
Frédéric Forget is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 37 papers that have together received 516 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Oncology (251 citations), Hepatology (67 citations) and Hematology (86 citations). Frédéric Forget has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Gaston Demonty, Fernando Rivera, Meinolf Karthaus, Xuesong Guan, Isabel Sevilla, Gianpiero Fasola, Howard Safran, Lee S. Schwartzberg, J. Randolph Hecht and Jean-Luc Canon. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.